DE19610635A1 - Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie - Google Patents
Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-TherapieInfo
- Publication number
- DE19610635A1 DE19610635A1 DE19610635A DE19610635A DE19610635A1 DE 19610635 A1 DE19610635 A1 DE 19610635A1 DE 19610635 A DE19610635 A DE 19610635A DE 19610635 A DE19610635 A DE 19610635A DE 19610635 A1 DE19610635 A1 DE 19610635A1
- Authority
- DE
- Germany
- Prior art keywords
- estrogen
- dosage units
- medicament according
- hydroxy
- dien
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19610635A DE19610635A1 (de) | 1996-03-11 | 1996-03-11 | Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie |
DE59712593T DE59712593D1 (de) | 1996-03-11 | 1997-03-11 | Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie |
JP9532200A JP2000506175A (ja) | 1996-03-11 | 1997-03-11 | ホルモン補充療法のための順次併用型エストロゲン/プロゲステロンアンタゴニストの組み合わせ |
EP97920535A EP0889727B1 (de) | 1996-03-11 | 1997-03-11 | Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie |
HU9901474A HUP9901474A3 (en) | 1996-03-11 | 1997-03-11 | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
BR9708162A BR9708162A (pt) | 1996-03-11 | 1997-03-11 | Combinação de antagonista estrogênio/progesterona sequencial para a terapia de substituição hormonal |
PT97920535T PT889727E (pt) | 1996-03-11 | 1997-03-11 | Combinacao sequencial estrogenio/ antagonista da progesterona para terapia hormonal de substituicao |
DK97920535T DK0889727T3 (da) | 1996-03-11 | 1997-03-11 | Sekventiel estrogen/progesteron-antagonist-kombination til hormonerstatningsterapien |
ES97920535T ES2260792T3 (es) | 1996-03-11 | 1997-03-11 | Combinacion secuencial de un estrogeno y de un antagonista de progesterona para la terapia por reemplazo de hormonas. |
AU26911/97A AU2691197A (en) | 1996-03-11 | 1997-03-11 | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
IL12617697A IL126176A (en) | 1996-03-11 | 1997-03-11 | Pharmaceutical packaging unit containing estrogen and progesterone antagonist for stepwise hormonal therapy |
PCT/DE1997/000580 WO1997033589A1 (de) | 1996-03-11 | 1997-03-11 | Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie |
CA002248841A CA2248841C (en) | 1996-03-11 | 1997-03-11 | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
KR1019980707136A KR19990087672A (ko) | 1996-03-11 | 1997-03-11 | 호르몬 대체 치료를 위한 순차적 에스트로겐/프로게스테론길항제 배합 |
AT97920535T ATE319454T1 (de) | 1996-03-11 | 1997-03-11 | Sequentielle estrogen/progesteronantagonist- kombination für die hormonersatz-therapie |
PL97328809A PL328809A1 (en) | 1996-03-11 | 1997-03-11 | Sequential combination of oestrogen and of competitive progesterone antagonist for hormonal vicarious treatment |
NO19984166A NO324613B1 (no) | 1996-03-11 | 1998-09-10 | Anvendelse av en sekvenskombinasjon av ostrogen/progesteronantagonister for fremstilling av et legemiddel for hormonerstatningsterapi |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19610635A DE19610635A1 (de) | 1996-03-11 | 1996-03-11 | Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie |
Publications (1)
Publication Number | Publication Date |
---|---|
DE19610635A1 true DE19610635A1 (de) | 1997-09-18 |
Family
ID=7788657
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19610635A Ceased DE19610635A1 (de) | 1996-03-11 | 1996-03-11 | Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie |
DE59712593T Expired - Fee Related DE59712593D1 (de) | 1996-03-11 | 1997-03-11 | Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE59712593T Expired - Fee Related DE59712593D1 (de) | 1996-03-11 | 1997-03-11 | Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0889727B1 (xx) |
JP (1) | JP2000506175A (xx) |
KR (1) | KR19990087672A (xx) |
AT (1) | ATE319454T1 (xx) |
AU (1) | AU2691197A (xx) |
BR (1) | BR9708162A (xx) |
CA (1) | CA2248841C (xx) |
DE (2) | DE19610635A1 (xx) |
DK (1) | DK0889727T3 (xx) |
ES (1) | ES2260792T3 (xx) |
HU (1) | HUP9901474A3 (xx) |
IL (1) | IL126176A (xx) |
NO (1) | NO324613B1 (xx) |
PL (1) | PL328809A1 (xx) |
PT (1) | PT889727E (xx) |
WO (1) | WO1997033589A1 (xx) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034126A2 (en) * | 1999-08-31 | 2001-05-17 | Jenapharm Gmbh & Co. Kg | Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
US7629334B1 (en) | 1999-08-31 | 2009-12-08 | Bayer Schering Pharma Aktiengesellschaft | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19834931A1 (de) * | 1998-07-28 | 2000-02-24 | Jenapharm Gmbh | Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie |
IL145838A (en) * | 2000-10-16 | 2008-11-03 | Pfizer Prod Inc | Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis |
EP1210951B1 (en) * | 2000-11-30 | 2005-02-02 | Pfizer Products Inc. | Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
-
1996
- 1996-03-11 DE DE19610635A patent/DE19610635A1/de not_active Ceased
-
1997
- 1997-03-11 BR BR9708162A patent/BR9708162A/pt not_active Application Discontinuation
- 1997-03-11 CA CA002248841A patent/CA2248841C/en not_active Expired - Fee Related
- 1997-03-11 DK DK97920535T patent/DK0889727T3/da active
- 1997-03-11 IL IL12617697A patent/IL126176A/en not_active IP Right Cessation
- 1997-03-11 PT PT97920535T patent/PT889727E/pt unknown
- 1997-03-11 AU AU26911/97A patent/AU2691197A/en not_active Abandoned
- 1997-03-11 HU HU9901474A patent/HUP9901474A3/hu unknown
- 1997-03-11 JP JP9532200A patent/JP2000506175A/ja not_active Ceased
- 1997-03-11 KR KR1019980707136A patent/KR19990087672A/ko not_active Application Discontinuation
- 1997-03-11 EP EP97920535A patent/EP0889727B1/de not_active Expired - Lifetime
- 1997-03-11 DE DE59712593T patent/DE59712593D1/de not_active Expired - Fee Related
- 1997-03-11 AT AT97920535T patent/ATE319454T1/de not_active IP Right Cessation
- 1997-03-11 PL PL97328809A patent/PL328809A1/xx unknown
- 1997-03-11 WO PCT/DE1997/000580 patent/WO1997033589A1/de active IP Right Grant
- 1997-03-11 ES ES97920535T patent/ES2260792T3/es not_active Expired - Lifetime
-
1998
- 1998-09-10 NO NO19984166A patent/NO324613B1/no unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034126A2 (en) * | 1999-08-31 | 2001-05-17 | Jenapharm Gmbh & Co. Kg | Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
WO2001034126A3 (en) * | 1999-08-31 | 2001-11-22 | Jenapharm Gmbh | Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
EA007840B1 (ru) * | 1999-08-31 | 2007-02-27 | Шеринг Акциенгезельшафт | Мезопрогестины (модуляторы рецептора прогестерона) в качестве компонента композиций для заместительной гормональной терапии (згт) |
US7629334B1 (en) | 1999-08-31 | 2009-12-08 | Bayer Schering Pharma Aktiengesellschaft | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
CZ301412B6 (cs) * | 1999-08-31 | 2010-02-24 | Bayer Schering Pharma Aktiengesellschaft | Použití specifických mesoprogestinu jako farmaceutické složky pro výrobu léciva pro hormonální substitucní lécbu |
Also Published As
Publication number | Publication date |
---|---|
NO324613B1 (no) | 2007-11-26 |
BR9708162A (pt) | 1999-07-27 |
CA2248841C (en) | 2008-07-22 |
NO984166L (no) | 1998-09-10 |
EP0889727B1 (de) | 2006-03-08 |
HUP9901474A3 (en) | 2000-02-28 |
DK0889727T3 (da) | 2006-07-03 |
HUP9901474A2 (hu) | 1999-09-28 |
CA2248841A1 (en) | 1997-09-18 |
EP0889727A1 (de) | 1999-01-13 |
IL126176A (en) | 2004-12-15 |
ES2260792T3 (es) | 2006-11-01 |
PL328809A1 (en) | 1999-02-15 |
PT889727E (pt) | 2006-07-31 |
WO1997033589A1 (de) | 1997-09-18 |
AU2691197A (en) | 1997-10-01 |
ATE319454T1 (de) | 2006-03-15 |
NO984166D0 (no) | 1998-09-10 |
DE59712593D1 (de) | 2006-05-04 |
KR19990087672A (ko) | 1999-12-27 |
IL126176A0 (en) | 1999-05-09 |
JP2000506175A (ja) | 2000-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0723439B1 (de) | Kombination von progesteronantagonisten und antiöstrogenen mit partialer agonistischer wirkung für die hormonsubstitutions-therapie für peri- und postmenopausale frauen | |
DE69532894T2 (de) | Verfahren zur empfängnisverhütung | |
DE19739916C2 (de) | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen | |
DE69427529T2 (de) | Hormon-ersatztherapie | |
DE69804918T2 (de) | Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung | |
DE69710896T2 (de) | Progestogen-anti-progestogen therapien | |
DE69532927T2 (de) | Cyclophasiges hormonverfahren das antiprogestin und progestin enthält | |
EP0628312B1 (de) | Kombinationspräparat zur Kontrazeption | |
DE69729956T2 (de) | Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält | |
EP0799042A1 (de) | Progesteronantagonistisch- und antiöstrogen wirksame verbindungen zur gemeinsamen verwendung für die weibliche kontrazeption | |
DE69327319T2 (de) | Minimierung von mit progesteron verbundenen durchbruckblutungen | |
EP0735881A1 (de) | Mittel und verfahren zur hormonalen kontrazeption und/oder zur aknebehandlung | |
DE4330234A1 (de) | Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten | |
EP2285383A2 (de) | Sequentielle verarbeitung von 20,20,21,21-pentafluor-17-hydroxy-11 -ý4-(hydroxyacetyl) phenyl¨-19-nor-17 -pregna-4,9-dien-3-on und einem oder mehreren gestagenen zur behandlung gynäkologischer erkrankungen | |
WO2000006175A1 (de) | Verwendung von biogenen estrogenssulfamaten zur hormonsubstitutionstherapie | |
EP0787002B1 (de) | Kompetitive progesteronantagonisten zur bedarfsorientierten weiblichen fertilitätskontrolle | |
DE602004009288T2 (de) | Verwendung einer kombination eines aromatasehemmers, eines progestins und eines oestrogens zur behandlung von endometriose | |
EP0889727B1 (de) | Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie | |
DE3787386T2 (de) | In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung. | |
WO1995005828A1 (de) | PROGESTERONANTAGONISTISCH- UND ANTIÖSTROGEN WIRKSAME VERBINDUNGEN FÜR DIE BEHANDLUNG DES $i(LEIOMYOMATA UTERI) | |
BG106443A (bg) | Мезопрогестини (прогестерон рецептор модулатори) като компонент на състави за хормонозаместваща терапия | |
AU2003206424B2 (en) | Sequential estrogen/progesterone antagonist combination for hormone replacement therapy | |
EP0814803A2 (de) | Verwendung von antiestrogenen zur männlichen fertilitätskontrolle | |
DE4406915A1 (de) | Ovulationshemmendes Mittel zur hormonalen Kontrazeption | |
DE19510861A1 (de) | Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
8127 | New person/name/address of the applicant |
Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE |
|
8131 | Rejection |